Eur Respir J 1997; 10: 2014-2017
Copyright © ERS Journals Ltd 1997
Maximal work capacity in relation to nutritional status in children with cystic fibrosis
VA Gulmans,
K de Meer,
HJ Brackel,
and
PJ Helders
In children with cystic fibrosis, objective parameters of exercise tolerance are needed which are easy to measure in nonspecialized centres. We investigated maximal workload (W'max) in children with cystic fibrosis in relation to body weight and fat-free mass, and compared this with results for maximal oxygen consumption (V'O2,max). Fourteen patients with cystic fibrosis performed an incremental maximal exercise test on a bicycle ergometer. W'max, V'O2,max, body weight and fat-free mass were measured. W'max and V'O2,max were significantly correlated (r = 0.91; p < 0.001). Using standard deviation scores in relation to reference values, W'max and V'O2,max per kilogram body weight were significantly higher than uncorrected W'max and V'O2,max (mean difference (95% CI) 0.63 (0.24-1.01) and 0.91 (0.32-1.49) SD units, respectively). There was no such difference after correction for fat-free mass. Standardized V'O2,max was significantly higher than standardized W'max (mean difference (95% CI): 1.59 (1.14-2.04)), also after correction for body weight and fat-free mass. In children with mild-to-moderate cystic fibrosis, maximal workload per kilogram fat-free mass, but not per kilogram body weight, is a useful parameter to correct for diminished nutritional status. In these patients, maximal workload is consistently lower than maximal oxygen consumption. Taking into account this difference, maximal workload and maximal workload per kilogram fat-free mass can be used for follow-up of paediatric patients with cystic fibrosis in nonspecialized settings.
This article has been cited by other articles:

|
 |

|
 |
 
E. F. McKone, S. C. Barry, M. X. FitzGerald, and C. G. Gallagher
Role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis
J Appl Physiol,
September 1, 2005;
99(3):
1012 - 1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. C. Klijn, A. Oudshoorn, C. K. van der Ent, J. van der Net, J. L. Kimpen, and P. J. M. Helders
Effects of Anaerobic Training in Children With Cystic Fibrosis: A Randomized Controlled Study
Chest,
April 1, 2004;
125(4):
1299 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. C. Klijn, J. van der Net, J. L. Kimpen, P. J. M. Helders, and C. K. van der Ent
Longitudinal Determinants of Peak Aerobic Performance in Children With Cystic Fibrosis
Chest,
December 1, 2003;
124(6):
2215 - 2219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Roef, K. de Meer, S. C. Kalhan, H. Straver, R. Berger, and D.-J. Reijngoud
Gluconeogenesis in humans with induced hyperlactatemia during low-intensity exercise
Am J Physiol Endocrinol Metab,
June 1, 2003;
284(6):
E1162 - E1171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Roef, D.-J. Reijngoud, J. A.L. Jeneson, R. Berger, and K. de Meer
Resting oxygen consumption and in vivo ADP are increased in myopathy due to complex I deficiency
Neurology,
April 9, 2002;
58(7):
1088 - 1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J Roef, K. de Meer, D.-J. Reijngoud, H. W. Straver, M. de Barse, S. C Kalhan, and R. Berger
Triacylglycerol infusion does not improve hyperlactemia in resting patients with mitochondrial myopathy due to complex I deficiency
Am. J. Clinical Nutrition,
February 1, 2002;
75(2):
228 - 236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J Roef, K. de Meer, D.-J. Reijngoud, H. W. Straver, M. de Barse, S. C Kalhan, and R. Berger
Triacylglycerol infusion improves exercise endurance in patients with mitochondrial myopathy due to complex I deficiency
Am. J. Clinical Nutrition,
February 1, 2002;
75(2):
237 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. de MEER, V. A. M. GULMANS, and J. van der LAAG
Peripheral Muscle Weakness and Exercise Capacity in Children with Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
March 1, 1999;
159(3):
748 - 754.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the European Respiratory Society.
|